Select Page

COVID Vaccination Centre @ RxDx Healthcare

  • COVAXIN is available
  • COVISHIELD is available
  • SPUTNIK V (1st Dose) is available (RxDx Whitefield only)
  • ZyCov-D (coming soon)

COVID-19 Vaccine for Children at RxDx

We are expecting ZyCoV-D Vaccine in late September or early October depending on the manufacturing schedule of Zydus Cadila.

To receive an alert regarding the availability of ZyCoV-D, we request you to fill the online form.


We can open COVISHIELD vials only if 10 beneficiaries have been confirmed for one particular slot. This action will help curb any vaccine wastage.

Request for COVID Vaccine Availability Alert
(Preferably Mobile No.)

ZyCoV-D Update

The world’s first approved Plasmid DNA vaccine has received the DCGI nod. Here are some critical points based on the queries you have sent us about ZyCoV-D.

Age group

The Cadila Vaccine has received the EUA for adults and 12-18 years old adolescent children.


ZyCoV-D is administered with the Pharmajet needle-free applicator called Tropis, a painless intradermal delivery method. Zydus has claimed that the technique reduces possible side effects of vaccination significantly.

Dose schedule

The 3-dose regimen for ZyCoV-D goes like 1st dose on day 0, 2nd dose on day 28, and 3rd dose on day 56.

The Company has also evaluated a two dose regimen for ZyCoV-D vaccine using a 3 mg dose per visit and the immunogenicity results had been found to be equivalent to the current three dose regimen.

Stability & Storage

The Plasmid DNA Vaccine is stable at 2-8 degrees C for upto three months. ZyCoV-D is easy to store, transport, and cold-chain breakdown won’t lead to immediate wastage with its thermostability.

Plasmid DNA

Circular DNA pieces that are different from the chromosomal DNA but can replicate inependantly are called plasmids. The plasmid carrying genetic information on the SARS-CoV-2’s spike protein is introduced between the dermal layers of the human body.

The Plasmid DNA platform also allows generating new constructs quickly to deal with mutations in the virus, such as those already occurring.


Zydus Cadila’s press release explains the well-established efficacy and immunogenicity. The advanced technology of this Plasmid DNA platform allows it to trigger humoral or extracellular immunity as well as the cellular response through the release of phagocytes, T cells, cytokines and chemokines in response to antigen. The Cadila vaccine has shown a primary efficacy of 66.6% in symptomatic RT-PCR positive patients during the interim analysis. No moderate case of COVID-19 disease was observed in the vaccine arm after the administration of 3rd dose suggesting 100% efficacy for moderate disease. No severe cases or deaths due to COVID-19 occurred in the vaccine arm after administration of the second dose of the vaccine. The Plasmid DNA platform also allows generating new constructs quickly to deal with mutations in the virus, such as those already occurring.

Information collected from this press release by Zydus Cadila.

Vaccination Pricing


S. No
Vaccine Name#
Cost* in Clinics ()
Dedicated Counters for 2 hours in Clinics for min. 30 beneficiaries
1 COVISHIELD 780 150
2 COVAXIN 1410 150
3 SPUTNIK V 1145 150

* Prices are subject to change. #Vaccination is subject to stock availability


Looking at the rising COVID cases in Bengaluru, healthcare service providers have been encouraged to ramp up the vaccine drive. Doorstep vaccination in gated apartments and societies is a big step in covering the target group in large numbers. More people can receive vaccine in the comfort of their own societies or workplaces. All you need is a tie-up with a government-authorized COVID Vaccination Centre (CVC) such as RxDx.

RxDx, your friendly neighbourhood healthcare chain has administered over 20,000 doses through their CVCs across the 5 flagship facilities in Bengaluru. Our dedicated COVID Vaccine Team has started running onsite camps for workplaces as soon we received the nod.

We will be able to visit your societies for the drive as soon as we have the vaccine stock.


All citizens aged 18 years and above can register for vaccination on the Co-WIN portal.

Due to the population size and vaccine demand, the CVCs can provide for a limited number of on-spot registration slots every day.

Vaccine Doses for Special Cases

NEGVAC recommendations on COVID-19 vaccination in special situations, accepted by the MoHFW:

  • Anybody who had a lab test proven SARS-Cov-2 illness before any COVID-19 vaccine dose are to differ their 1st shot for 3 months after recovery
  • If someone has COVID infection after 1st dose before completion of the entire schedule, 2nd dose is to be deferred for 3 months from clinical recovery
  • Any COVID-19 patient who has received anti-SARS-Cov-2 monoclinal antibodies or convalescent plasma therapy need to defer their vaccination for 3 months after discharge from the hospital
  • Those who had any other serious general illness (non-COVID-19) which required hospitalisation or ICU care also need to wait for 4-8 weeks before getting the vaccine
  • Citizens can donate blood after 14 days of receiving the COVID-19 vaccine or testing RT-PCR negative after having the infection
  • NEGVAC recommends COVID vaccination for all lactating women. MoHFW resonates
  • Before vaccination, recipients do not need to get Rapid Antigen Test

It is advisable for a COVID recovered person to receive complete schedule of COVID vaccine irrespective of past history of infection with COVID-19. This will help in developing a strong immune response against the disease.

What’s unique about COVID vaccination at RxDx?


Shots are administered by trained vaccinators


Doctors are available for pre-and-post vaccination consultations, if needed


Exclusive areas have been created for smooth, seamless and quick turnaround


Support is available for verification and on-the-spot registration


Support is available for downloading the vaccination certificates


Trained staff available for Vaccination counselling on the floor


Our own cold chain logistics are maintained across all branches

RxDx has been rated high by beneficiaries who received their shots since beginning of inoculation in Bengaluru. Here are a few expression from the testimonials:

  • “Kind treatment”
  • “Smooth and Seamless”
  • “Didn’t even feel the jab”
  • “Quick”
  • “Helpful Staff”
  • “Feel honoured by your services”
  • “Efficient staff”
  • “Cleared doubts”
  • “Nurse was very nice”

2nd Dose Schedule

According to the latest GOI guidelines, the Optimal Dose Interval for the vaccines available in India right now are:

COVAXIN: 4 – 6 weeks (28-48 days)
COVISHIELD: 12 – 16 weeks (84-112 days)
SPUTNIK V: 3 weeks – 3 months (21-90 days)
ZyCoV-D schedule: 1st dose on day 0; 2nd dose on day 28th; 3rd dose on day 56th

Vaccination is subject to stock availability.

2nd Dose For International Travel

As per government guidelines, if you are in Bengaluru and requesting for 2nd dose Covishield administration after 28 days but before 84 days, for international travel purposes, then you need to visit Central College Campus, Bengaluru City University between 10:30 am and 4:30 pm. This is the only CVC that is authorized to conduct vaccination for such beneficiaries. No other CVC is presently authorized for this purpose in Bengaluru.

Central College Campus, Dr Ambedkar Rd, Bengaluru, Karnataka 560001.

Documents of such beneficiaries will be verified by competent government officials. Beneficiaries should refer to the eligibility guidelines attached herewith or visit the website of RxDx to read a summary of the government guidelines: to check their eligibility. They don’t need to go anywhere else for documentation or permission etc., for their 2nd dose.

If the beneficiaries are found eligible, they will be granted permission to take the 2nd dose. The 2nd dose will be administered on the same day in Central College Campus.

For more details, citizens can contact Sanghamitra, Deputy Health Officer (East) on 9343793046, Dr Gayatri, Medical Officer on 9591879025, or Dr Mohammed Aleef Ali, Medical Officer on 9880037365.

Administration of Second Dose of Covishield Vaccine Prior to Prescribed Time Interval (after 28 days but before 84 days) to persons intending to undertake international travel for education purpose, for joining employment in foreign countries and for India’s contingent to Tokyo Olympics.

  1. States/UT governments shall designate a competent authority in each District for according permission for such administration of second dose of Covishield.
  2. The competent authority shall check the following before according a permission for administration of second dose before the period of 84 days after the date of first dose –
    1. Whether a period of 28 days has elapsed after the date of first dose.
    2. Genuineness of the purpose of travel based on documents related to –
      1. Admission offers or associated formal communications for the purpose of education.
      2. Whether a person is already studying in a foreign educational institution and has to return to that institution for continuing his/her education.
      3. Interview calls for a job or offer letters for taking up employment
      4. Nomination to participate in the Tokyo Olympic Games.
  3. It is advised that vaccination may be availed in such cases through Passport which is one of the permissible ID documents as per the current guidelines, so that the passport number is printed in the vaccination certificate. However, if Passport was not used at the time of administration of first dose, the details of the photo ID Card used for vaccination will be printed in the vaccination certificate and mention of the Passport in the vaccination certificate is not to be insisted upon. Wherever necessary, the competent authority may issue another certificate linking the vaccination certificate with the passport number of the beneficiary.
  4. This facility shall be available to those who need to undertake international travel for these specified purposes in the period up to 31st August, 2021.
  5. All technical protocols as prescribed in the Guidelines of the Ministry regarding COVID Vaccination Centres and AEFI management etc. shall have to be followed.
  6. It is clarified that Covishield, produced by the Serum Institute of India and approved by the DCGI, is one of the vaccines recognised by the WHO for emergency use as on 3rd June 2021. The relevant entry is at S.No. 4 of the WHO EUL, available at
    Mention of vaccine type as “Covishield” is sufficient and no other qualifying entries are required in the vaccination certificates.
  7. The Co-WIN system will soon provide the facility for administration of 2nd dose in such exceptional cases.
  8. This is to clarify that these SOPs have been issued specifically only for Covishield because only the time interval between the 2 doses of Covishield has been increased from 6-8 weeks to 12-16 weeks. The period for COVAXIN has remained the same i.e. 4-6 weeks and hence there was no need for any special dispensation for 2nd dose of COVAXIN. It is also clarified that complete vaccination with COVAXIN is also sufficient for foreign travel.


COWIN Portal: If you are registering on the portal from your browser:

  1. Visit
  2. Click Register/Sign In yourself
  3. Enter your mobile number
  4. Enter the OTP received via SMS
  5. Select the photo ID proof you wish to submit
  6. Enter your demographic details (best to keep it same as the Photo ID)
  7. You can add up to 4 members using one mobile number
  8. Select Schedule Now
  9. Select Schedule Appointment
  10. You will be asked to enter:
    Pin code
  11. Click search to look for Vaccination Centres near you

As of now, due to shortage of vaccine, you may not see any CVC near you. Try searching with pin codes around you or wait for a few days.

Once you are registered, you can visit the portal again to schedule your appointment when possible.

Aarogya Setu Portal: If you wish to register through the Aarogya Setu app

  1. Download the Aarogya Setu App from Play Store or App Store
  2. Complete the installation and registration process
  3. Open the app and click on the Vaccination icon
  4. Enter your mobile number
  5. Continue as described for
For Whitefield Branch, type 560066 and press enter Scroll down the Centre Name window to select and click on RxDx Whitefield S1 P3
For Siddapura branch, type 560066 and press enter Scroll down the Centre Name window to select and click on RxDx Siddapura P3
For Kadugodi branch, type 560067 and press enter Scroll down the Centre Name window to select and click on RxDx Kadugodi P3
For Bellandur branch, type 560103 and press enter Scroll down the Centre Name window to select and click on RxDx Bellandur P3
For Malleswaram branch, type 560003 and press enter Scroll down the Centre Name window to select and click on RxDx Samanvay
  • Choose your preferred date and time as per slot availability
  • Click Book to complete your registration Process

  Branch wise Time-Table: COVID Vaccination Centre RxDx Healthcare (wef. Oct 4, 2021)

Branch Name COWIN Site Name Pin Code Days COVISHIELD (pre-registered & Walk-in-beneficiaries) COVAXIN (pre-registered & Walk-in-beneficiaries) SPUTNIK V DOSE 1 (pre-registered & Walk-in-beneficiaries) SPUTNIK V DOSE 2 (pre-registered & Walk-in-beneficiaries)
RxDx Whitefield RxDx Whitefield S1 P3 560 066 Daily 09:00 am –  05:00 pm 09:00 am –  08:00 pm 12:00 pm –     08:00 pm 12:00 pm –      2:00 pm
RxDx Kadugodi RxDx Kadugodi P3 560 067 Mon-Sat 01:00 pm –  04:00 pm 01:00 pm –  05:00 pm NA NA
RxDx Bellandur RxDx Bellandur P3 560 103 Mon-Sat 08:30 am –    12:30 pm 08:30 am –  04:30 pm NA NA
RxDx CHANDY RxDx Siddapura P3 560 066 Mon-Sat 01:00 pm –  04:00 pm 09:00 am –  05:00 pm NA NA
RxDx SAMANVAY, Malleswaram RxDx SAMANVAY 560 003 Mon-Sat 10:00 am  –   05:00 pm 10:00 am –  05:00 pm NA NA


As per Government Guidelines, COVISHIELD vials will be opened ONLY WHEN 10 beneficiaries are confirmed and SPUTNIK V Dose 2 ONLY WHEN 5 beneficiaries are confirmed for a particular slot. This will help curb vaccine wastage.

As of now, there is NO such requirements for COVAXIN or SPUTNIK V DOSE 1.

We request your cooperation

Ways to reach us:


WhatsApp: +91 901 996 1402

Phone: + 91 901 409 1111

Contact us Form

*Vaccination is subject to availability of stock.

#For Vaccination Schedule on Govt. Holidays, please call our Patient Experience Centre +91 901 409 1111 or WhatsApp on +91 901 996 1402


You have to select any of these during registration and carry the same in original with you during your vaccination.

Age proof with photo identity (any one of these):

  • Aadhar Card
  • Passport
  • PAN
  • Driving License
  • Electoral Photo Identity Card (EPIC) – Voter ID Card
  • NPR smart card
  • Pension document with photograph


Please verify your certificate before leaving the RxDx Covid Vaccination Centre. Speak with any RxDx Staff if you haven’t received the message for downloading your vaccination certificate.

Steps to download the Certificate without beneficiary ID

  1. Go to:
  2. Click on Register Yourself
  3. Update Registered Phone number
  4. Click on Get OTP
  5. Update OTP and click Verify
  6. Your details will appear
  7. Click on CERTIFICATE box to download certificate

Didn’t get the Vaccination Certificate?

While you are in the vaccination centre at RxDx, please CONTACT Mr Prasun Dutta, RxDx, 9886512567

    Or else, share the following details with us URGENTLY:

  • Name of the Beneficiary:
  • Date of Vaccination:
  • Mobile number (which was used for vaccination):

Please send above details via any ONE of these methods ONLY:


Recommendations regarding COVID Vaccination during pregnancy and lactation

MoHFW and WHO recommends that pregnant women and lactating mothers can take the COVID vaccines Covishield, Covaxin, Sputnik V, and Moderna. COVID vaccine-induced antibodies may pass from breastfeeding mother to child and offer them some protection from the highly infectious disease. Dr VK Paul, Member-Health, Niti Aayog, also stated that Vaccine has no association with infertility.
Download the Government Guidelines.

Watch: Episode #41 – Vaccines, pregnancy, menstruation, lactation and fertility

Who should avoid COVID vaccination during pregnancy or lactation?

Anybody including pregnant women and lactating mothers should not take the vaccine if they have a history of:

  • Anaphylactic or allergic reaction to the previous dose of COVID-19 vaccine
  • Anaphylaxis or allergic reaction to vaccines or injectable therapies, pharmaceutical
  • products, food-items etc.

Booster Shot
As of now, all COVID vaccines available are double-dosed. Since it’s not clear that the two shots can give life-long protection from the SARS-Cov-2, speculations are going on regarding the need of more vaccine shots to boost the immunity build up.

Dr Soumya Swaminathan. Chief Scientist, the WHO, has stated that the consideration of booster shot for those already vaccinated is too premature. High-risk population across the world haven’t received their first shot yet. Their 2nd dose should be prioritised before a booster dose is considered for people who have already received 2 shots.

COVID Vaccination
Now, you can book your slot for COVID-19 Vaccination through the Paytm App.

Vaccination Drive for Special Groups in Karnataka
Sportspersons travelling for the Tokyo Olympics can get vaccinated from June 22 (Tuesday) at Bengaluru City University Campus, said Deputy Chief Minister and state COVID-19 Task Force head Dr CN Ashwath Narayan. Students and professionals who are travelling abroad can also join this drive. Those receiving their first shot of Covishield in this drive can take their 2nd jab 28 days after the 1st.

COVID vaccine for children
ZyCoV-D by Zydus Cadila awaits emergency use authorisation from the DGCI. Clinical trials for this vaccine in children of age group 12-18 years have ended. As a three-dose vaccine ZyCoV-D is recommended for children and adults in following schedule:
2nd dose: 28 days after 1st
3rd dose: 56th day from 1st

Covaxin trials are going on in children of age group 12-18 years.

Internationally, Pfizer-BioNTech’s vaccine has been approved for children.

The revision in dose interval is only meant for Serum Institute of India’s Covishield and not Bharat Biotech’s Covaxin.

The updated dose interval has come up after the results of the recent Late-Stage US trials became available to the public.

AstraZeneca carried out a Late-stage human trial with 32,449 volunteers across all age groups above 18 years, in the US.

Symptomatic disease prevention: 79% Efficacy

Severe disease and hospitalisation prevention: 100% Efficacy

Among age group of 65 and above: 80% Overall Efficacy

No risk of blood clotting events in participants who had received at least one dose of the vaccine.

COVID 2.0, India

New case count:
925 in Bengaluru
1488 in Karnataka

Karnataka is stepping up the Vaccination Coverage to 3 Lakh per day and COVID Testing up to 1 lakh a day. Focus is on Bengaluru Urban which is currently contributing to 72% of the total positive cases in the state. 12 containment zones have been identified as of today.

12% of the new COVID cases are among patients who have travelled recently or attended some event or visited public places like shopping malls.

Phase 3 of the Vaccination Drive in India has commenced from March 1, 2021.

If you are above 45 years of age and have one of the conditions listed by government as COVID comorbidity, or you are above 60 years of age, you can self-register on the Co-WIN 2.0 app.

Onsite registration is available at government and empanelled private hospitals.

COVID-19 vaccine is scheduled for roll-out in the country on 16th January 2021 and the states/UTs have already received vaccines for the same.

In this regard, a comparative factsheet for both the vaccines that will be used during the introduction have been prepared which contains information on vaccine platform, physical specifications, dosage, cold chain storage requirements, contraindications and minor AEFIs. A detailed note on contraindications and special precautions has also been prepared and is enclosed.

Source: Office of Additional Secretary, Ministry of Health & Family Welfare, dated January 14, 2021

Know More

Indian vaccine candidates Bharat Biotech’s Covaxin and Oxford-Astrazeneca’s Covishield got the DCGI nod for restructured emergency use authorization.

Covishield is in phase 3 trials in India but global data show that this vaccine has an overall efficacy of 70.42%. Recommended doses: age group >18 years, 2 shots, 4-6 weeks apart, intramuscular. As per media reports, possible price in India: around ₹400.

Covaxin has just started phase 3 Clinical Trials and more data is required. Recommended doses: 2 shots, Day 0 and 28. As per media reports, possible price in India: less than ₹100.

Vaccination will be initially prioritised for beneficiaries like healthcare and other front-line workers. Clinical trials will continue. DCGI and other authorities will keep monitoring the new strain reported.

India has been conducting vaccine dry runs across several states to prepare for the actual drive. Drills include registration, verification, mock vaccination, and post-shot observations.


On COVISHIELD and clotting:

Dr VK Paul, NITI Aayog member and the co-chair of the government-constituted expert group on vaccination, assured, “We have no signal of concern in that regard.” So far, no causal link has been established and hence, Covishield vaccination is to “go on in full rigour”.

European Medicines Agency has announced that the AstraZeneca vaccine is not associated with an overall higher risk of clots and is safe and effective.

Health experts advise informing doctors and nurses about existing blood coagulation disorders to take precautions if needed before vaccine administration.

AstraZeneca, the collaborator of the AstraZeneca-Oxford vaccine, stated that only 37 out of 17 million vaccinations in the EU and UK reported blood clots. They also confirmed that the evidence of no increase in blood coagulation after vaccination was very reassuring.

With the rise of COVID cases in the city, ramping up the Testing and priority group vaccination to protect their vulnerability from disease severity are of paramount importance now.


As of now, these citizen groups have received the COVID shots (1st or both)

  1. Healthcare workers
  2. Frontline workers
  3. Elderly citizens (>60 years)
  4. Citizens in the age group of 45-59 years with one or more of the comorbidities as per government list


Citizens in the order as follows:

  1. Those above 45 haven’t received their 2nd dose
  2. Above 45 waiting for their 1st dose
  3. All adults above 18 (subject to availability)

NEGVAC recommends COVID vaccination for Lactating mothers. MoHFW has accepted.


The vaccines currently available in India are not recommended by the manufacturers for women who are pregnant or planning to get pregnant.
Vaccine trials in children are awaited.

Five principles guiding the vaccination drive

Technology-driven well-planned implementation

Existing healthcare services like national programmes and primary care will remain uncompromised 

Apply the strategies of elections and universal immunisation programme

Ensure participation of the general population

Strict adherence to scientific and regulatory norms and other SOPs

Race for COVID Vaccine in India

Currently, around 30 COVID Vaccine candidates are in various stages of development in our country.

Covishield and COVAXIN are already in use.

COVID Vaccines in India


Inactivated Viral Vector

Bharat Biotech

Authorised for public vaccination


Non-Replicating Viral Vector

Serum Institute of India (SII) + ICMR

Authorised for public vaccination


Plasmid DNA vaccine

Zydus Cadila

Authorised for public vaccination (12 years and above)

Sputnik V

Non-Replicating Viral Vector

Dr Reddys Laboratories Limited + Sputnik LLC

Authorised for public vaccination

BECOV2 (A, B, C, D)

Protein Subunit

Biological E + US-based Dynavax + Baylor College of Medicine

Phase I/II ongoing


Protein Nanoparticle + Novavax’s proprietary Matrix-M adjuvant

SII + Novavax

Phase II/III approval received


mRNA (India’s first; can be stored at around 2 to 8˚ C)

Genova + HDT Biotech Company

Phase 1 ongoing

2019-nCoV vaccine 3mg (two dose schedule)

Live Weakened Recombinant Measles Virus Vector-Based

Zydus Cadila (Etna Biotech)

Phase I/II approval received


Inactivated Adenovirus Nasal Spray Vaccine

Bharat BioTech + Washington University School of Medicine

Phase I approval received


Multitope Peptide-based Vaccine

Aurobindo Pharmaceuticals + COVAXX

Submitted proposal for Phase II/III

Vaccines: What are they?

Not a treatment.

Vaccines follow the classic principle of “Prevention is better than cure.”

A vaccine is a natural or genetically engineered, weakened or inactive form of the pathogen itself. When transferred to the host body, it trains the immune system to fight the infection if contracted in future.

What are we looking for, in the highly anticipated novel Coronavirus vaccine?

  • Dosage
  • Safety
  • Efficacy
  • Ease of Storage and Distribution
  • Mechanism of Action (MOA)
  • Cost
    Not necessarily in that order.

How does a vaccine work against viral infections?

Virus only replicates when it finds a living host. The vaccine stops that replication, hence spreading, as a result, either prevents sickness or reduces symptom severity from the infection. The pathogen dies eventually.

Steps of Vaccine Development

Vaccine development is a long, slow, sequential process, but the COVID crisis has forced our hands. Fastest developed vaccine was for mumps. It took 4 years. The phases of vaccine development:
  1. Preclinical phase

Testing out a potential vaccine in animals or laboratory environment

  1. Clinical phase

Phase I
Examine dosage, efficacy, safety, and possible side effects of candidate vaccine in a small group of people (30-50)

Phase II
Look for immunogenicity (does the vaccine elicit expected immune response?) besides safety and efficacy

Phase III
More advanced stage of testing the candidate vaccine’s safety and efficacy along with large scale monitoring of adverse events. Chances of approval are related to the risk benefit ratio.

Who approves vaccines for manufacturing?

Companies file Biological License Approval (BLA) requests with regulatory authorities like FDA (US), MHRA (UK), DCGI (India), TGA (Australia) with safety and efficacy data on vaccines and other pharmaceutical products.
The regulators keep up the scrutiny even after approval process is over, to ensure continued safety.

Safety recap







A round-up on the novel coronavirus vaccines

Most of the COVID vaccines are intramuscular shots, to be administered in two doses, at 21-28 days interval. FDA has voted in favour of the Pfizer vaccine for COVID stating that benefit outweighs risk in population 16 years of age and above. Pfizer is adding a warning in the labelling indicating that Appropriate medical treatment and supervision should be readily available in case of anaphylaxis. This happened due to a few severe allergic reactions reported in UK and USA. The Oxford-AstraZeneca vaccine was temporarily stalled when a case of neurological issue was reported in a woman which was reported to be possibly related to her pre-existing medical condition and not the vaccine.

Vaccines mostly have low to mild effects, mostly commonly fatigue, muscle aches, mild fever, etc which is more about body’s response to the shot than the disease


Those who have COVID infection should wait for complete recovery before getting the vaccine but there is no contraindication so far for patients who have had a previous SARS-CoV-2 infection.

As we see a lot of contradiction regarding the concept of immunisation, doubt often creeps in our mind. Do we really need vaccines? Do they harm more than benefit us? Should I wait for my neighbour to try it out?
We need to remember that vaccines are the best way to prevent infectious diseases.

Remember small pox, remember polio, remember tetanus! Then, ask yourself, are vaccines good or bad for you.

Truly, nothing is risk-free in this world. The speed at which COVID has set the vaccine race, many find it concerning. However, technology of vaccine development is way more advanced compared to what we knew even a decade ago. Also, in today’s world, everything happens under the watchful eyes of the public, the government, regulatory authorities and the media. So, let’s set our worries aside and wait for our turn to get that preventive shot against the pandemic.


on COVID-19 Vaccine

Do I have to take the 2nd dose of vaccination?

Yes. Both shots of the currently available vaccines must be taken to expect the full benefit of immunisation. Both doses must be of the same vaccine type.

When should I take the 2nd dose of vaccination?

For the vaccines currently available in India,

Recommended interval is 4 to 6 weeks.

Recommended interval is 12 to 16 weeks.

Recommended interval is 3 weeks to 3 months.

Beneficiaries are advised to reschedule their prebooked slots accordingly. However, if a pre-booked beneficiary chooses to have a shot on a scheduled day, even if it’s less than 84 days, they must not be turned away, provided stock is available.

Will my 2nd dose appointment be automatically scheduled by Co-WIN system?

No. You have to take an appointment for the 2nd dose vaccination. You can check the Co-WIN portal to book an appointment in a Vaccination Centre where the same type (your 1st dose) of vaccine is being administered (COVAXIN or COVISHIELD).

Whom can I contact if I have some problems related to my online registration of appointment?

You can call on the national helpline ‘1075’ for information and guidance on COVID-19 vaccination and Co-WIN software related queries.
Can I walk-in to RxDx for my 2nd dose?
Yes. Depending upon the COVID-19 vaccine availability in the respective branches, you can walk in for your dose. However, we do suggest that you book your slots through CoWIN for your convenience.
Is it necessary for a COVID recovered person to take the vaccine?
Yes, it is advisable to receive complete schedule of COVID vaccine irrespective of past history of infection with COVID-19. This will help in developing a strong immune response against the disease.
If I had COVID-19 infection, when can I take my first dose?
Anybody who had a lab test proven SARS-Cov-2 illness before any COVID-19 vaccine dose are to differ their 1st shot for 3 months after recovery.
What to do if one gets infected after the first dose of the vaccine?
If someone has COVID infection after 1st dose before completion of the entire schedule,2nd dose is to be deferred for 3 months from clinical recovery
Can patients who have been treated with plasma take the vaccine? When should they take the 1st dose?
Any COVID-19 patient who has received anti-SARS-Cov-2 monoclinal antibodies or convalescent plasma therapy need to defer their vaccination for 3 months after discharge from the hospital.
When can anybody with other serious non-COVID illness take the vaccine?
Those who had any other serious general illness (non-COVID-19) which required hospitalisation or ICU care also need to wait for 4-8 weeks before getting the vaccine
After a COVID infection or vaccination, how long does one need to wait before donating blood?
Citizens can donate blood after 14 days of receiving the COVID-19 vaccine or testing RT-PCR negative after having the infection.
Can breastfeeding mothers get the vaccine?
NEGVAC recommends COVID vaccination for all lactating women.
Is it necessary to take the Rapid Antigen Test before vaccine?
Before vaccination, recipients do not need to get Rapid Antigen Test.
When will RxDx start vaccination in old age homes?
RxDx can run any kind of vaccination only once the stock is available. You can email us your requirement however, so we can get in touch when we are ready for you.
Do I need a vaccine certificate?
A COVID Vaccine Certificate (CVC) issued by the government offers an assurance to the beneficiary on the vaccination, type of vaccine used, and the provisional certificate also provides the next vaccination due. It also is an evidence for the citizen to prove to any entities which may require proof of vaccination specially in case of travel. Vaccination not only protects individuals from disease, but also reduces their risk of spreading the virus. Therefore, there could be a requirement in future to produce certificate for certain kind of social interactions and international travel. In this context the certificate issued by Co-WIN has built in security features to guarantee genuineness of the certificate which can be digitally verified using approved utilities which are provided in Co-WIN portal.
Will I receive a certificate after my vaccination?
After your shot (first and second, both), please request for a digital copy of your certificate. You can also download vaccination certificate from the Co-WIN portal ( or the Aarogya Setu app by using the mobile number used at the time of registration.
What is the cost of vaccination at RxDx?
Upon stock availability, we will adhere to prices declared by manufacturers for private organisation, until further notice of change.

COVISHIELD: ₹850 / dose
COVAXIN: ₹1,250 / dose
SPUTNIK V: ₹1145 / dose

Which Vaccine did we get at RxDx?
RxDx has administered COVISHIELD and COVAXIN. These were being supplied centrally by the BBMP authorities, Bengaluru.
Whom to contact in case of side effects from vaccination?
You can reach out through:

Government Helpline Number: +91-11-23978046 (Toll free- 1075)

Technical Helpline Number: 0120-4473222

Helpline Email Id:

You can also contact RxDx to consult a doctor if you experience any issues after your vaccination.

Dr Guleria, Director, AIIMS sharing FAQs on COVID 19 vaccine rollout


What can we do better?

Not much. Everything was professionally handled.

A Madhav Rao

My experience was excellent & memorable. The entire staff right from receptionist, nurse, Doctor to helpers were excellent. They made me feel I belong to RxDx.
K P Giridhar

Super responsive staff.
Santosh Goel

Taken the vaccine at RxDx thus writing to send my feedback n to let the entire team know that the procedure was totally smooth very efficient n quick. Sending my heartfelt thanks to Sunita, Arjun n the entire RxDx team who are really doing a wonderful job. Congratulations! One n all
Sandra Maheshwari

I am senior citizen, and I have taken COVID vaccination in this hospital at white field. I have found this hospital clean and hygienic. All staff have a cordial behavior. In the end, I am giving a thumbs up for the services which your staff render. Very happy! Hope to live up to the same standard.
Fariha Fathima

At the outset I wish to thank you Dr Noah, for recommending RXDX, for taking our first dose of covid vaccination for my wife and I. I am extremely happy to inform you that the hospitality extended to us when we visited the hospital today was truly professional. I found that every staff right at the entrance till the nurse who administered the vaccine were so courteous and affable. Dr Vijaya was kind enough to expeditiously issue a medical certificate for my wife who has comorbidity. Those at the reception at the 1st floor and 3rd floor, those who verified our identity proof were all so helpful, efficient and well mannered. The nurse who gave us the injection was also very polite, experienced and friendly. We neither felt any pain nor realised that we have already been injected. While we were asked to take rest for 30 min, an elderly gentleman spoke motivating words to us while enquiring as to how we felt after the vaccination. It was truly a unique experience on our maiden visit to RXDX and I once again thank you for directing us to the right hospital.

Saju Alexander

Your services are really excellent. You replied my every mail. As a senior citizen, I feel honoured by your services. Keep it up. My best wishes.
Arun Kumar

Visit us

Plot No. 7G, Opp. Graphite India
Kundalahalli Main Road
Whitefield Bengaluru – 560 048
P: 901 409 1111

Site No 34/1 B, First Floor
Above Domino’s Pizza
Opposite Sai Baba Ashram
Kadugodi Bengaluru – 560 067
P: 901 409 1111

Directions :

C/o RxDx Healthcare
8A, Ground Floor, The Bay
Marathahalli-Sarjapur Outer Ring Road
Adarsh Palm Retreat
Bengaluru – 560103
P: 901 409 1111

Directions :

66/1, Miraya Rose,
Bengaluru – 560066
P: 901 409 1111

Directions :

#29, 11th Main Road
Near Cluny Convent High School
Bengaluru – 560 003
P: 901 409 1111